公司概覽
業務類別 Medical Devices
業務概覽 Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
公司地址 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
電話號碼 +1 224 667-6100
傳真號碼 --
公司網頁 https://www.abbott.com
員工數量 115000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 美元 1.50M 13/03/2026
Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 美元 924.23K 20/02/2026
Mr. Eric Shroff Senior Vice President, Rapid and Molecular Diagnostics -- 20/02/2026
Mr. Christopher J. Scoggins Executive Vice President, Diabetes Care 美元 859.50K 20/02/2026
Ms. Mary K. Moreland Executive Vice President, Human Resources -- 20/02/2026
Ms. Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 美元 924.23K 20/02/2026
Mr. Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer 美元 974.23K 20/02/2026
Mr. Louis H. Morrone Executive Vice President, Core Diagnostics -- 20/02/2026
Ms. Elizabeth C. Cushman Executive Vice President, General Counsel and Secretary -- 20/02/2026
Mr. John A. Mccoy, Jr Vice President, Finance, Controller and Principal Accounting Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. John G. Stratton Independent Director 13/03/2026
Ms. Nancy Mckinstry Lead Independent Director 13/03/2026
Dr. Sally E. Blount, PhD Independent Director 13/03/2026
Mr. Michael F. Roman Independent Director 13/03/2026
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 13/03/2026
Mr. Daniel J. Starks Independent Director 13/03/2026
General Darren W. McDew, U.S.A.F. (Ret.) Independent Director 13/03/2026
Ms. Patricia P. Gonzalez Independent Director 13/03/2026
Mr. Kevin Conroy Independent Director 27/04/2026
Ms. Michelle A. Kumbier Independent Director 13/03/2026
Mr. Michael G. O’Grady Independent Director 13/03/2026
Ms. Claire Babineaux-Fontenot Independent Director 13/03/2026
Ms. Nita Ahuja, M.D. Independent Director 13/03/2026
 
所屬ETF (更新日期: 02/05/2026 04:57)
代號 名稱 佔比% 持有日期
TACUT. Rowe Price Active Core U.S. Eq ETF0.00002%29/04/2026
INCMFranklin Income Focus ETF0.00001%29/04/2026
BALQiShares Nasdaq Premium Income Active ETF0.00001%28/04/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00001%28/04/2026
BBBCYBER HORNET S&P500 Bitcoin 75/25StgyETF0.00001%29/04/2026
TRUHVaneck Healthcare TruSector ETF0.00001%29/04/2026
SNPDXtrackers S&P Div Arstcrts Scrn ETF0.00001%29/04/2026
VOXPVox Populi ETF0.00001%29/04/2026
GOFGuggenheim Strategic Opp Fund0.00001%30/11/2025
GXLCGlobal X U.S. 500 ETF0.00001%29/04/2026
XCLRGlobal X S&P 500® Collar 95-110 ETF0.00001%29/04/2026
XTRGlobal X S&P 500® Tail Risk ETF0.00001%29/04/2026
AVOSAvos Global Equities ETF0.000004%29/04/2026
ESMViShares ESG Optd MSCI USA Min Vol FacETF0.000004%29/04/2026
MHIGMilliman Healthcare Inflation Guard ETF0.000004%29/04/2026
PEVCPacer PE/VC ETF0.000004%29/04/2026
FBProshares S&P 500 Dynamic Buffer ETF0.000002%28/02/2026
GLBLPacer MSCI World Industry Advantage ETF0.000002%29/04/2026
QFHDPacer S&P 500 Quality FCF High Div ETF0.000002%29/04/2026
AAEQAlpha Architect US Equity 2 ETF<0.000001%30/03/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17   18    19    20    21    22    23    24  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.